Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 306 recruiting now early-phase tilt #3 of 28,963 conditions

Obesity: early-phase trial registry

306 of 1,057 indexed Obesity trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3 of 28,963 conditions by registered trial count.

1,057 US clinical trials · 306 currently recruiting · #3 of 28,963 conditions by registered trial count

Obesity: 1,057 US clinical trials tracked, 306 recruiting.

Obesity is the subject of 1,057 registered US clinical trials on ClinicalTrials.gov, 306 of them currently open to new participants. 107 are in Phase 3-4 (later-stage) and 196 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 48 of these trials.

Open enrollment, early-phase tilt

Obesity has 1,057 registered US clinical trials, 306 of them open to new participants right now, about 29% of the total.

306
recruiting participants now
29%
of trials open to enrollment
107
in Phase 3-4 (later-stage)
48
top sponsor: Eli Lilly and Company

Corpus placement: #3 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Obesity on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Obesity is recruiting below its size-band peers.

    306 of 1,057 indexed trials (28.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Obesity trials is spread across many organizations.

    Eli Lilly and Company accounts for 48 of 1,057 trials (4.5%). 314 distinct sponsors appear on at least one study for this condition label.

  3. Typical Obesity enrolment sits around 90 participants.

    Median target enrolment is 90 among the 1,054 trials that report a genuine target (sentinel values excluded). 555 of those (52.7%) plan for fewer than 100 participants.

  4. Obesity research is mostly interventional.

    894 interventional and 163 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 195Phase 2101Phase 369Phase 438

Open and recent trials

1,057 total, page 21 of 22

COMPLETED NA 18 participants

Vitamin D and Adipose Tissue Inflammation

Fred Hutchinson Cancer Center

NCT01477034

COMPLETED 18 participants

Pharmacokinetics of Implanon in Obese Women

University of Chicago

NCT00724438

COMPLETED NA 18 participants

The Natriuretic Peptide Response to Saline Infusion

Vanderbilt University Medical Center

NCT04223531

COMPLETED 18 participants

Impact of Metabolic Flexibility on Changes in Metabolic Health

Pennington Biomedical Research Center

NCT06340321

COMPLETED NA 18 participants

Child Care Wellness Study on Nutrition and Physical Activity

University of North Carolina, Chapel Hill

NCT01921842

COMPLETED NA 18 participants

Preventing Weight Gain in African American Reproductive-Aged Women

Washington University School of Medicine

NCT02416921

COMPLETED NA 18 participants

Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

University of Illinois at Chicago

NCT05796648

COMPLETED NA 18 participants

A Trial of Lifestyle Interventions to Control Weight After Bariatric Surgery

Beth Israel Deaconess Medical Center

NCT02603601

COMPLETED NA 17 participants

Obesity, Iron Regulation and Colorectal Cancer Risk

University of Illinois at Chicago

NCT03548948

COMPLETED NA 17 participants

ClockWork Postpartum Weight Management Study

University of Pittsburgh

NCT04992637

COMPLETED NA 16 participants

Neurohormonal & Behavioral Correlates of Obesity and Weight Loss

University of Michigan

NCT02063451

COMPLETED NA 16 participants

Whole Grains, Gastric Emptying and Glycemic Response

Purdue University

NCT03467659

COMPLETED NA 16 participants

Characterization of Bile Acid Pathway in Obesity

Mayo Clinic

NCT03341052

COMPLETED NA 16 participants

Acute Exercise on Brain Insulin Sensitivity

Rutgers, The State University of New Jersey

NCT05853913

COMPLETED NA 15 participants

Exercise and Nutrition Program in Improving Physical Activity and Dietary Behavior in Non-Active, Overweight, or Obese Latinas

OHSU Knight Cancer Institute

NCT03028935

COMPLETED 15 participants

Effects of Regular Activity on Physiology Between Recreational Athletes of Different Body Fatness

Florida State University

NCT05154422

COMPLETED NA 15 participants

Effect of Food Order on Postprandial Glucose Excursions in Pre-Diabetes

Weill Medical College of Cornell University

NCT03536364

COMPLETED 15 participants

Free-Living Physical Activity and Energy Expenditure

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00062998

COMPLETED NA 15 participants

Effects of Exercise on Cardiac Fat in Women With Obesity: a Pilot Study

Texas Tech University

NCT02589327

COMPLETED NA 15 participants

WorkWell: Work-based Activity and Metabolic Health

Arizona State University

NCT04269070

COMPLETED NA 14 participants

Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents

Yale University

NCT01901978

COMPLETED Phase 1 14 participants

Effect of Administration of Itraconazole on the Pharmacokinetics of S-309309 in Healthy Participants

Shionogi

NCT06106334

COMPLETED NA 13 participants

Identification of Muscle-specific Biomarkers of Fatty Acid Beta-oxidation

USDA, Western Human Nutrition Research Center

NCT01494025

COMPLETED 13 participants

Pilot Study of Strength Testing in Overweight Women With or Without Insulin Resistance

National Heart, Lung, and Blood Institute (NHLBI)

NCT01862757

COMPLETED NA 13 participants

Glycomacropeptide and Women's Health

University of Wisconsin, Madison

NCT05551091

COMPLETED NA 13 participants

Sleep, Exercise and Insulin Sensitivity

University of Missouri-Columbia

NCT03556410

COMPLETED NA 12 participants

The Effects of Alcohol Consumption on Central Adiposity

Pennington Biomedical Research Center

NCT03521817

COMPLETED Phase 2 12 participants

The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes

Mayo Clinic

NCT02762708

COMPLETED NA 12 participants

A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling

The University of Texas Health Science Center at San Antonio

NCT01740817

COMPLETED 12 participants

Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men

Freeman-Sheldon Research Group

NCT02532725

COMPLETED NA 12 participants

FFA Hypertension and Inflammation in Lean and Obese Subjects

Emory University

NCT00721617

COMPLETED NA 12 participants

PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia

University of California, San Diego

NCT01171599

COMPLETED NA 12 participants

Online Resources to Manage Obesity and Health Risks in an Employee Wellness Program

Vanderbilt University

NCT01122420

COMPLETED NA 10 participants

Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study

Rush University Medical Center

NCT04637477

COMPLETED 10 participants

Implementation of a Cardiometabolic Disease Staging System in Primary Care

University of Alabama at Birmingham

NCT04922294

COMPLETED Early Phase 1 10 participants

Mediators of Abnormal Reproductive Function in Obesity (MARO)

University of Colorado, Denver

NCT01817400

COMPLETED Phase 1 10 participants

Endoscopic Gastric Reduction for Weight Management

Mayo Clinic

NCT01682733

COMPLETED NA 10 participants

Sleep Restriction and Postprandial Lipemia

University of Missouri-Columbia

NCT05713370

COMPLETED 10 participants

Sex Differences in Gene Expression in Human Adipose Tissue

University of California, San Diego

NCT00677651

COMPLETED 10 participants

Kid STRIDE: Exploring Participation in a Family-based Intervention

University of Wisconsin, Madison

NCT00682422

COMPLETED Early Phase 1 10 participants

Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women

Rockefeller University

NCT01901679

COMPLETED NA 9 participants

Influence of a Monopoly Game on Subtle Behaviors

University of Colorado, Denver

NCT02470949

COMPLETED NA 9 participants

Endoscopic Suturing System for Tissue Apposition

Ethicon Endo-Surgery

NCT00495222

COMPLETED NA 8 participants

The Effects of Leucine on Body Weight

Columbia University

NCT00683826

COMPLETED NA 8 participants

Effects of Exercise for Overweight Women With Polycystic Ovary Syndrome

Pennington Biomedical Research Center

NCT01150539

COMPLETED 8 participants

Detection of Brown Adipose Tissue by Magnetic Resonance Imaging

University of North Carolina, Chapel Hill

NCT02237872

COMPLETED NA 8 participants

Timing of Meals for Weight Loss

The University of Tennessee, Knoxville

NCT02204735

COMPLETED NA 8 participants

Effects of a Calorie Restricted, Very Low Fat Plant-based Diet and Multi-component Exercise Program on Metabolic Health

Washington University School of Medicine

NCT02706288

COMPLETED NA 7 participants

Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity

University of Michigan

NCT01451957

COMPLETED Phase 1 6 participants

Effects of Glucagon Administration on Energy Expenditure

AdventHealth Translational Research Institute

NCT02237053

← Previous Page 21 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 95
Phase 2 101
Phase 3 69
Phase 4 38

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Obesity right now

306 recruiting of 1,057 indexed (29% open).

Phase mix: 107 late (III/IV) vs 196 early (I/II) (early-phase heavy).

Top sponsor: Eli Lilly and Company (48 trials), 9 others listed. 50 shown below, recruiting first. #3 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Obesity?

PlainTrial tracks 1,057 US clinical trials for Obesity, of which 306 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Obesity?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.